Clavulanic acid
- CAS No.
- 58001-44-8
- Chemical Name:
- Clavulanic acid
- Synonyms
- brl14151;Clavulanate acid;3008-b;C06662;MM-14151;Clavulansaeure;CLAVULANIC ACID;antibioticmm14151;Clavulanate Monomer;Clavulanic acid USP/EP/BP
- CBNumber:
- CB9722501
- Molecular Formula:
- C8H9NO5
- Molecular Weight:
- 199.16
- MDL Number:
- MFCD00867004
- MOL File:
- 58001-44-8.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Boiling point | 545.8±50.0 °C(Predicted) |
|---|---|
| Density | 1.65±0.1 g/cm3(Predicted) |
| storage temp. | 4°C, protect from light, stored under nitrogen |
| solubility | H2O : 50 mg/mL (251.05 mM; Need ultrasonic) |
| form | Solid |
| pka | 3.68±0.20(Predicted) |
| color | Off-white to light yellow |
| FDA UNII | 23521W1S24 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
Clavulanic acid price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Usbiological | 268964 | Calvulanic Acid ≥98% | 58001-44-8 | 1mg | $418 | 2026-06-03 | Buy |
| Usbiological | 268964 | Calvulanic Acid ≥98% | 58001-44-8 | 5mg | $602 | 2026-06-03 | Buy |
| Usbiological | 268964 | Calvulanic Acid ≥98% | 58001-44-8 | 10mg | $784 | 2026-06-03 | Buy |
| Usbiological | 268964 | Calvulanic Acid ≥98% | 58001-44-8 | 25mg | $998 | 2026-06-03 | Buy |
| Usbiological | 268964 | Calvulanic Acid ≥98% | 58001-44-8 | 50mg | $1237 | 2026-06-03 | Buy |
Clavulanic acid Chemical Properties, Uses, Production
Description
Clavulanic acid is a mold product with only weak intrinsic antibacterial activity, but it is an excellent irreversible inhibitor of most β-lactamases. It is believed to acylate the active site serine by mimicking the normal substrate. Hydrolysis occurs with some β-lactamases, but in many cases, subsequent reactions occur that inhibit the enzyme irreversibly. This leads to its classification as a mechanism-based inhibitor (or so-called suicide substrate). The precise chemistry is not well understood, but when clavulanic acid is added to ampicillin and amoxicillin preparations, the potency against β-lactamase–producing strains is markedly enhanced.
Chemical Properties
Sodium Clavulanate (Sodium Clavulanate): C8H8NNaO5. white needle-like crystals, melting point 68 ° C, [α] D20 + 47.1 ° (C = 1, water). Potassium Clavulanate (Potassium Clavulanate): C8H8KNO5. colorless needle-like crystals, soluble in water, but aqueous solution is not stable.
Originator
Augmentin,Beecham,UK,1981
Uses
beta-lactamase inhibitor
Definition
ChEBI: Antibiotic isolated from Streptomyces clavuligerus. It acts as a suicide inhibitor of bacterial beta-lactamase enzymes.
Manufacturing Process
100 ml of sterile water was added to a sporing culture which had been grown
on Bennetts agar in a Roux bottle for 10 days at 26°C. A mycelium/spore
suspension was produced and used to inoculate 75 liters of steam sterilized
medium of the following composition in tap water.
Arkasoy is soybean flour supplied by British Arkady Co., Old Trafford,
Manchester, UK
The pH of the medium was adjusted to 7.0
The medium was contained in a 100 liter stainless steel baffled fermenter,
agitated by a 7.5 inch vaned disc impeller at 140 rpm. Sterile air was supplied
at 75 liters per minute and the tank incubated for 72 hours at 26°C.
The contents of the seed fermenter were used to inoculate 1,500 liters of
steam sterilized medium of the following composition in tap water.
10% Pluronic L81 in soybean oil 0.2% V/V
The pH of the medium was adjusted to 7.0
The medium was contained in a 2,000 liter stainless steel fully baffled
fermenter agitated by two 19 inch vaned disc impellers at 106 rpm.
Sterile air was supplied at 1,200 liters per minute. Antifoam was added in 25
ml amounts as required. (10% Pluronic L81 in soybean oil). The fermentation
was controlled at 26°C until a maximum yield of clavulanic acid was obtained
between 3-5 days when 200-300 μg/ml of clavulanic acid were produced.
Therapeutic Function
Antibacterial
World Health Organization (WHO)
The amoxicillin/clavulanic acid combination should be reserved for infections likely or known to be caused by amoxicillin- resistant beta-lactamase producing strains. Amoxicillin/clavulanic acid is listed in the WHO Model List of Essential Drugs.
Antimicrobial activity
It exhibits broad-spectrum but low intrinsic activity, most MICs being in the range 16–128 mg/L. Enterobacteriaceae and Staph. aureus are among the more sensitive and Ps. aeruginosa the most resistant organisms. MICs of 8 mg/L against H. influenzae and 0.1–4 mg/L for penicillinase-producing N. gonorrhoeae are notable.
General Description
Clavulanic acid was found in the culture broth of Streptomyces clavuligerus by Beecham Research Laboratories in 1976. It was the first β-lactamase inhibitor. This antibiotic shows weak antibacterial activity against grampositive and gram-negative organisms but strong inhibitory activity against the β-lactamase produced by ampicillin-resistant bacteria. Clavulanic acid is used orally in combination with amoxicillin and with ticarcillin by injection to enhance the activities of these antibiotics against resistant infections.
Pharmacokinetics
It exhibits broad-spectrum but low intrinsic activity, most MICs being in the range 16–128 mg/L. Enterobacteriaceae and Staph. aureus are among the more sensitive and Ps. aeruginosa the most resistant organisms. MICs of 8 mg/L against H. influenzae and 0.1–4 mg/L for penicillinase-producing N. gonorrhoeae are notable.
Clinical Use
Clavulanic acid is an antibiotic isolated from Streptomycesclavuligeris. Structurally, it is a 1-oxopenam lacking the6-acylamino side chain of penicillins but possessing a 2-hydroxyethylidene moiety at C-2. Clavulanic acid exhibitsvery weak antibacterial activity, comparable with that of6-APA and, therefore, is not useful as an antibiotic. Itis, however, a potent inhibitor of S. aureus β-lactamaseand plasmid-mediated β-lactamases elaborated by Gramnegativebacilli.
Combinations of amoxicillin and the potassium saltof clavulanic acid are available (Augmentin) in variousfixed-dose oral dosage forms intended for the treatment ofskin, respiratory, ear, and urinary tract infections causedby -lactamase–producing bacterial strains. These combinationsare effective against β-lactamase–producingstrains of S. aureus, E. coli, K. pneumoniae, Enterobacter,H. influenzae, Moraxella catarrhalis, and Haemophilusducreyi, which are resistant to amoxicillin alone. The oral bioavailability of amoxicillin and potassium clavulanate issimilar. Clavulanic acid is acid-stable. It cannot undergo penicillanicacid formation because it lacks an amide side chain.Potassium clavulanate and the extended-spectrum penicillinticarcillin have been combined in a fixed-dose, injectableform for the control of serious infections caused byβ-lactamase–producing bacterial strains. This combinationhas been recommended for septicemia, lower respiratory tractinfections, and urinary tract infections caused by β-lactamase–producing Klebsiella spp., E. coli, P. aeruginosa,and other Pseudomonas spp., Citrobacter spp., Enterobacterspp., S. marcescens, and S. aureus. It also is used in bone andjoint infections caused by these organisms. The combinationcontains 3 g of ticarcillin disodium and 100 mg of potassiumclavulanate in a sterile powder for injection (Timentin).
Synthesis
Clavulanic acid is isolated from Streptomyces clavuligerus [60–66], and sulbactam, a sulfone of penicillanic acid, is synthesized from 6-APA [67–69]. Both compounds have extremely weak antibacterial properties and act by forming irreversible complexes with beta-lactamase, which inactivates the enzyme, and as a result the beta-lactam antibiotic has time to destroy the microorganism.
Clavulanic acid Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| Beijing HuaMeiHuLiBiological Chemical | 010-56205725 | waley188@sohu.com | China | 12323 | 58 |
| Guangzhou Isun Pharmaceutical Co., Ltd | 020-39119399 18927568969 | isunpharm@qq.com | China | 4773 | 55 |
| AdooQ BioScience, LLC | +1 (866) 930-6790 | info@adooq.com | United States | 2774 | 58 |
| Shanghai Macklin Biochemical Co.,Ltd. | 15221275939 15221275939 | shenlinxing@macklin.cn | China | 15775 | 55 |
| Chizhou Kailong Import and Export Trade Co., Ltd. | xg01_gj@163.com | China | 9413 | 50 | |
| Alta Scientific Co., Ltd. | 022-6537-8550 15522853686 | sales@altasci.com.cn | China | 4508 | 55 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Beijing Minruida Technology Co., Ltd. | 010-82387566 | sales@mreda.com.cn | China | 19323 | 58 |
Related articles
- Clavulanic acid: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.
- Clavulanic acid is a naturally occurring beta-lactamase inhibitor which was isolated from Streptomyces clavuligerus (Reading a....
- Mar 17,2022
View Latest Price from Clavulanic acid manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-07-23 | Clavulanic Acid
58001-44-8
|
$40.00-58.00 | 99.98% | 10g | TargetMol Chemicals Inc. | ||
 |
2020-01-14 | Clavulanic acid
58001-44-8
|
$1.00 | 1g | 99% | 200kg | Career Henan Chemical Co | |
|
|
2020-01-14 | Clavulanic acid
58001-44-8
|
$1.00 | 1g | 99% | 200kg | Career Henan Chemical Co |
-
- Clavulanic Acid
58001-44-8
- $40.00-58.00
- 99.98%
- TargetMol Chemicals Inc.
-
- Clavulanic acid
58001-44-8
- $1.00
- 99%
- Career Henan Chemical Co
-
- Clavulanic acid
58001-44-8
- $1.00
- 99%
- Career Henan Chemical Co
